Millennium Management’s Cerenome CNSY Stock Holding History

Millennium Management’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,864	Closed	-$44.2K	–	6302
2026 Q1	$44.2K	Buy	+10,864	New	+$82.4K	﹤0.01%	5449
2025 Q3	–	Sell	-969	Closed	-$8.43K	–	6376
2025 Q2	$8.43K	Buy	+969	New	+$12.7K	﹤0.01%	5724
2023 Q4	–	Sell	-790	Closed	-$26.5K	–	6447
2023 Q3	$26.5K	Buy	+790	New	+$42.4K	﹤0.01%	5597
2023 Q2	–	Sell	-186	Closed	-$20K	–	6574
2023 Q1	$20K	Sell	186 -179	-49%	-$24.1K	﹤0.01%	5865
2022 Q4	$43K	Buy	365 +332	+1,006%	+$52.9K	﹤0.01%	5827
2022 Q3	$6K	Sell	33 -24	-42%	-$5.36K	﹤0.01%	6770
2022 Q2	$12K	Buy	+57	New	+$14.2K	﹤0.01%	6620
2016 Q1	–	Hold	0	–	-$24K	–	3583
2015 Q4	–	Hold	0	–	–	–	3338
2015 Q3	–	Hold	0	–	–	–	3093
2015 Q2	–	Hold	0	–	–	–	2768
2014 Q1	–	Hold	0	–	-$140K	–	3809
2013 Q4	–	Hold	0	–	–	–	3306

Other funds holding CNSY

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Millennium Management's CNSY Position: Q2 2026 in Review

Millennium Management sold out of Cerenome (CNSY) in Q2 2026, closing a stake of 10,864 shares — an estimated $44.2K sold.

Millennium Management first reported a position in CNSY in Q2 2022 and held it in 7 quarters. The position peaked at $44.2K in Q1 2026. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

Millennium Management reported no remaining Cerenome position as of Q2 2026 after selling out during the quarter.
Millennium Management sold 10,864 Cerenome shares in Q2 2026, an estimated $44.2K.
Millennium Management first reported a position in Cerenome in Q2 2022 and held it in 7 quarters.
Millennium Management's Cerenome position peaked at $44.2K in Q1 2026.
21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.